Omentin-1 vs Buserelin
Head-to-head comparison of Omentin-1 (Omentin-1 (Intelectin-1, ITLN1)) and Buserelin (Buserelin acetate) — benefits, dosing, side effects, research data, and where to buy.
| Property | Omentin-1 | Buserelin |
|---|---|---|
| Category | Diabetes & Metabolic | Sexual Health |
| Full Name | Omentin-1 (Intelectin-1, ITLN1) | Buserelin acetate |
| Molecular Weight | ~35 kDa | 1239.39 Da |
| Half-Life | hours | ~50-80 minutes |
| Amino Acids | 313 | 9 |
| Typical Dose | No approved human dose; research use only | 200 mcg intranasal 3x daily|0.2-0.5 mg SC daily|depot per protocol |
| Route | IV|SC | Intranasal/Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 82 | 450 |
| Research Status | Pre-clinical | Clinical |
Omentin-1 Benefits
- ✓insulin sensitivity
- ✓glucose uptake
- ✓lipid handling
Buserelin Benefits
- ✓pituitary down-regulation
- ✓cycle synchronization
- ✓ovarian stimulation control
- ✓fertility protocol timing
Omentin-1 Dosing
not established|not established
Buserelin Dosing
200 mcg intranasal 3x daily|0.2-0.5 mg SC daily|depot injection per protocol
Omentin-1 Side Effects
- ⚠unknown
- ⚠immunogenicity risk
Buserelin Side Effects
- ⚠hot flashes
- ⚠headache
- ⚠initial LH/FSH flare
Research Overview
Omentin-1
Lower omentin-1 levels are often associated with obesity, insulin resistance, and metabolic syndrome. Research continues on its use as a biomarker and as a mechanistic lead for AMPK-linked metabolic interventions.
Buserelin
Buserelin has been studied extensively as a GnRH agonist in IVF down-regulation and other reproductive-endocrine protocols. Its use helped establish modern cycle-control approaches in assisted reproduction.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.